Dark

Check out our Level2View

BETRF
BETTERLIFE PHARMA INC
stock OTC

EOD

Jul 31, 2026

0.2084USD+18.342%(+0.0323)221,335

Pre-market

0.00USD-100.000%(-0.17)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 20, 2022

08:00AM EST BetterLife Receives FDA Response On Its Pre-IND Application For GlobeNewswire Inc

Jan 18, 2022

08:00AM EST BetterLife Obtains Positive In Vivo Oral Bioavailability, Food GlobeNewswire Inc

Jan 6, 2022

08:00AM EST Dr. Eleanor Fish, Advisory Board Member, Awarded Order of Canada GlobeNewswire Inc

Dec 22, 2021

10:30AM EST BetterLife Pharma Inc. (BetterLife or the Company) (CSE:BETR/OTCQB:BETRF/ FRA: NPAU) today announced that its wholly-owned subsidiary, Altum Pharmaceuticals Inc. (Altum), has signed an agreement with an European-based investor group to complete a non-brokered financing of up to US$5.0 million by way of private placement of Altums common shares. GlobeNewswire Inc

Dec 9, 2021

08:00AM EST BetterLife Obtains Positive TD-0148A Data in Preclinical Models of GlobeNewswire Inc

Dec 3, 2021

08:00AM EST H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE GlobeNewswire Inc

Nov 29, 2021

08:00AM EST BetterLife Successfully Completes Phase 1 and Initiates Phase 2 GlobeNewswire Inc

Nov 16, 2021

08:00AM EST BetterLife Obtains TD-0148A Behavioural Pharmacology Data GlobeNewswire Inc

Nov 5, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR /OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, will participate in a panel discussion at the Microdose Wonderland: Miami Conference, November 8-9, 2021. GlobeNewswire Inc

Nov 4, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR /OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that it has obtained the first set of neurological receptor functional binding data on its lead compound, 2-bromo-LSD (TD-0148A). GlobeNewswire Inc

Oct 18, 2021

01:37PM EDT Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation Benzinga

08:36AM EDT KCSA Psychedelics Virtual Investor Conference Presentations Available for PR Newswire

Oct 13, 2021

04:25PM EDT There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are Benzinga

Oct 12, 2021

08:00AM EDT Early Results of BetterLife Preclinical Study Show AP-003 GlobeNewswire Inc

Oct 11, 2021

08:20AM EDT KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th PR Newswire

Sep 29, 2021

08:00AM EDT BetterLife Obtains TD-0148A Receptor Binding Data for IND-Enabling GlobeNewswire Inc

Sep 27, 2021

08:00AM EDT BetterLife Files Patent for TD-0148A for Treatment of Cluster GlobeNewswire Inc

Sep 22, 2021

08:00AM EDT BetterLife Enrolls First Patient in Interferon alpha-2b COVID-19 GlobeNewswire Inc

Sep 14, 2021

07:00AM EDT EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 16th Emerging Growth Conference. GlobeNewswire Inc

Sep 13, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE:BETR/OTCQB:BETRF/ FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions, is pleased to announce that it has been invited to present at the Emerging Growth Conference on September 15, 2021. GlobeNewswire Inc

Sep 9, 2021

08:00AM EDT BetterLife Enters Research Agreement with Medical College GlobeNewswire Inc

Aug 25, 2021

08:00AM EDT BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) GlobeNewswire Inc

Aug 11, 2021

02:56PM EDT What Do You Really Know About Psychedelics And Psychedelics Stocks? Benzinga

Jul 22, 2021

08:00AM EDT BetterLife-Carleton University Research Team Secure Mitacs GlobeNewswire Inc

Jul 20, 2021

07:00AM EDT EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 12th Emerging Growth Conference. GlobeNewswire Inc

Jul 19, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE:BETR/OTCQB:BETRF/ FRA:NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions, is pleased to announce that it has been invited to present at the Emerging Growth Conference on July 21, 2021. GlobeNewswire Inc

Jul 12, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR /OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions, announces significant progress in H1 2021. GlobeNewswire Inc

Jun 24, 2021

08:00AM EDT BetterLife Secures Mitacs Funding in Collaboration with Carleton GlobeNewswire Inc

Jun 22, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE:BETR/OTCQB:BETRF/ FRA: NPAU), an emerging biotech company, is pleased to announce that it has engaged U.K.-based financial and corporate communications consultancy Buchanan Communications Ltd. (Buchanan). GlobeNewswire Inc

Jun 15, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE:BETR/OTCQB:BETRF/ FRA:NPAU), an emerging biotech company focused on non-hallucinogenic psychedelic therapeutics, today announced that Ahmad Doroudian, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021. GlobeNewswire Inc

Jun 10, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR /OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has retained Proactive Investors (Proactive) and Psychedelic Finance to broaden the Company's reach within a global investor network, as well as to assist with general market awareness. GlobeNewswire Inc

Jun 8, 2021

01:12PM EDT What Do You Really Know About Psychedelics And Psychedelics Stocks? Benzinga

Jun 2, 2021

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR /OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has appointed Mr. Henri Sant-Cassia, co-founder of The Conscious Fund, to its Board of Directors. GlobeNewswire Inc

May 14, 2021

08:00AM EDT BetterLife Announces Closing of a Non-Brokered Private Placement GlobeNewswire Inc

Apr 29, 2021

08:00AM EDT BetterLife Files Patent for Invention of Novel Subcutaneous GlobeNewswire Inc

Apr 8, 2021

08:00AM EDT Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins GlobeNewswire Inc

Apr 6, 2021

11:39AM EDT Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree Benzinga

Mar 29, 2021

08:00AM EDT BetterLife Added to Horizons Psychedelic Stock Index ETF GlobeNewswire Inc

Mar 11, 2021

08:00AM EST BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct GlobeNewswire Inc

Mar 8, 2021

08:46AM EST BetterLife Enters Research Agreement with Carleton University for GlobeNewswire Inc

Mar 3, 2021

08:00AM EST BetterLife Engages Eurofins CDMO for Next Generation Psychedelic GlobeNewswire Inc

Feb 16, 2021

07:30AM EST EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies announces the launch of the Emerging Growth Conference. GlobeNewswire Inc

07:00AM EST BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR /OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that it has been invited to present at the Emerging Growth Conference on February 17, 2021. GlobeNewswire Inc

Feb 2, 2021

08:30AM EST BetterLife Files Patent Protection on Dihydrohonokiol-B for GlobeNewswire Inc

Jan 28, 2021

02:00AM EST BetterLife Engages Eurofins Discovery for its Next Generation GlobeNewswire Inc

Jan 26, 2021

08:30AM EST BetterLifeDemonstrates 6 months Refrigerated Stability GlobeNewswire Inc

Jan 21, 2021

08:30AM EST BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in GlobeNewswire Inc

Jan 19, 2021

02:00AM EST BetterLife Confirms Non-controlled Status of 2-bromo-LSD with GlobeNewswire Inc

Jan 12, 2021

02:00AM EST BetterLife Provides Shareholder Update and 2021 Product GlobeNewswire Inc

Jan 7, 2021

09:00AM EST January 7, 2021 - BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce the formation of its Next Generation Psychedelic Research Advisory Board and appointment of highly experienced Ms. Hattie Wells as its first member. GlobeNewswire Inc

Jan 4, 2021

09:32AM EST January 4, 2021 - BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce it has applied for patent protection of new 2-Bromo-LSD (TD-0148A) formulations and their use in the treatment of depression and mood disorders. GlobeNewswire Inc

Dec 29, 2020

02:00AM EST BetterLife Pharma Inc. (BetterLife or the Company) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that it has added Mr. Sergei Stetsenko to its Board of Directors to prepare for its growth phase in psychedelic medicines. GlobeNewswire Inc

Dec 23, 2020

02:00AM EST BetterLife Welcomes Psychedelic Industry Leaders to the Senior GlobeNewswire Inc

Dec 21, 2020

02:00AM EST BetterLife Closes Acquisition of Second Generation Psychedelic GlobeNewswire Inc

Dec 15, 2020

02:00AM EST BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLCs (Transcend) manufacturing patent Process of synthesizing 2-Bromo-LSD. GlobeNewswire Inc

Dec 14, 2020

10:09AM EST Psyched: Canada Allows Psilocybin Use For Healthcare Pros, UK Begins DMT Trials, Cybin To Purchase Adelia Benzinga

Dec 8, 2020

08:56AM EST BetterLife adds Next-Gen Psychedelic Therapy to its Pipeline of Drugs GlobeNewswire Inc

Nov 18, 2020

07:30AM EST What do the Pfizer Vaccine and BetterLife Pharma have in common? GlobeNewswire Inc

Nov 10, 2020

07:30AM EST BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company focused on development and commercialization of interferon based treatments, today announced a clinical and regulatory update for its AP-003 COVID-19 clinical trials following discussions with the U.S Food and Drug Administration (FDA). GlobeNewswire Inc

Nov 4, 2020

08:00AM EST BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 GlobeNewswire Inc

Oct 28, 2020

08:00AM EDT BetterLife Pharma (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company preparing human clinical trials of AP-003, its interferon alpha 2b inhalation therapy for the treatment of COVID-19, today provided the following update regarding how it expects to overcome potential challenges of recruiting patients for human trials. GlobeNewswire Inc

05:00AM EDT UPDATE: BetterLife CEO Highlights Crucial Difference Between the Companys Interferon Alpha 2b and Synairgen PLCs Interferon Beta GlobeNewswire Inc

Oct 27, 2020

07:30AM EDT The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing for clinical trials of AP-003, its interferon alpha 2b COVID-19 treatment, joined investor portalProactiveto discuss the key differences between the interferon inhalation formula used by BetterLife against that used successfully by Synairgen PLC. GlobeNewswire Inc

Oct 15, 2020

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it has engaged the Clinical Research Organisation (CRO) Pharmaceutical Solutions Ltd. to manage its forthcoming clinical trial for AP-003 targeting mild to moderate cases of COVID-19 at research sites across Australia. GlobeNewswire Inc

Oct 8, 2020

08:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it will be teaming up with VirTrial, LLC (VirTrial) to conduct patient monitoring for their imminent COVID 19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation. GlobeNewswire Inc

Sep 30, 2020

07:30AM EDT BetterLife Receives FINRA Approval and Resumes Trading on the OTC GlobeNewswire Inc

Sep 23, 2020

07:30AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced that it has filed a Form 211 application with the Financial Industry Regulatory Authority (FINRA) to request permission to quote and resume trading of its securities on OTC Markets. GlobeNewswire Inc

Sep 17, 2020

07:30AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced it has entered into an agreement with List Biological Laboratories, Inc. (List Labs) for the manufacture of its proprietary interferon alpha 2b for the treatment of COVID-19. GlobeNewswire Inc

Sep 9, 2020

07:30AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced that Company CEO Dr. Ahmad Doroudian was interviewed by the Canadian Stock Exchange (CSE) to discuss Betterlifes post-merger business model and significant changes by management to position the Company for the future. GlobeNewswire Inc

Sep 8, 2020

07:30AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) is pleased to announce that it has retained Hybrid Financial Ltd. (Hybrid) to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for BetterLife and to broaden the Company's reach within the investment community. GlobeNewswire Inc

Sep 2, 2020

07:30AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company, today announced that Dr.Eleanor Fishwill continue to play a key role as part of the Company's Scientific Advisory Board after having been appointed, in recognition of her expertise in infectious diseases, to the Canadian Governments COVID-19 Task Force. GlobeNewswire Inc

Sep 1, 2020

07:30AM EDT BetterLife Resumes Trading Following CSE Merger Ratification with GlobeNewswire Inc

Aug 11, 2020

07:00AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) is pleased to announce that it has closed the first tranche of its non-brokered private placement (the "Offering") by issuing 716,725 units ("Units") at a price of $1.90 per Unit for gross proceeds of $1,361,777. GlobeNewswire Inc

Aug 5, 2020

07:30AM EDT BetterLife Announces Trading Halt Following Merger with Altum GlobeNewswire Inc

Jul 30, 2020

07:30AM EDT BetterLife Pharma Inc. (BetterLife or the Company) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company with proprietary interferon-based therapeutic technologies, is pleased to provide an update on the results of the Special Meeting of the shareholders of Altum Pharmaceuticals Inc. (Altum) to approve the merger with BetterLife. GlobeNewswire Inc

Jul 28, 2020

08:01AM EDT BetterLife CEO Discusses Synairgens Interferon GlobeNewswire Inc

Jul 27, 2020

11:55AM EDT BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its PR Newswire

Jul 24, 2020

04:30PM EDT BetterLife Pharma Inc. ("BetterLife" or the "Company") (OTCQB:BETRF / CSE: BETR /FRA: NPAT) provides the following information about certain promotional activities at the request of OTC Markets. GlobeNewswire Inc

Jul 23, 2020

08:00AM EDT BetterLife CEO Discusses Merger, Planned Interferon Treatment GlobeNewswire Inc

Jul 21, 2020

08:01AM EDT BetterLife Pharma Inc. ("BetterLife" or the "Company") (OTCQB:BETRD) (CSE:BETR) has been a strong advocate and defender of using interferons as treatment for COVID-19, in particular as delivered through an inhalation device. GlobeNewswire Inc

Jul 14, 2020

08:01AM EDT BetterLife (OTCQB:BETRD) Launches Website Emphasizing 3 GlobeNewswire Inc

Share